Safety and feasibility of trans‐venous cardiac device extraction using conscious sedation alone—Implications for the post‐COVID‐19 era

Abstract Background Transvenous lead extraction (TLE) for implantable cardiac‐devices is traditionally performed under general anesthesia (GA). This can lead to greater risk of exposure to COVID‐19, longer recovery‐times and increased procedural‐costs. We report the feasibility/safety of TLE using c...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Thomas Lachlan, Hejie He, Hesham Aggour, Preet Sahota, Samuel Harvey, Kiran Patel, Will Foster, Shamil Yusuf, Sandeep Panikker, Tarv Dhanjal, Uday Dandekar, Thomas Barker, Jitendra Parmar, Michael Kuehl, Faizel Osman
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	cardiac implantable electronic devices conscious‐sedation Fentanyl lead extraction Midazolam Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/3efcd0eb9d094b9c8d93a3edb776efa0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Safety and feasibility of trans‐venous cardiac device extraction using conscious sedation alone—Implications for the post‐COVID‐19 era

Documents similaires